Mode
Text Size
Log in / Sign up

Elevated peripheral HIF-1α levels associated with higher fasting glucose and HbA1c in patients with type 2 diabetes mellitus

Elevated peripheral HIF-1α levels associated with higher fasting glucose and HbA1c in patients…
Photo by Steve Johnson / Unsplash
Key Takeaway
Note that elevated peripheral HIF-1α associates with worse glycemic metrics but may reflect hypoxia compensation rather than disease causation.

This systematic review and meta-analysis evaluated the relationship between peripheral HIF-1α protein expression and glycemic control in 5,979 patients with type 2 diabetes mellitus. The analysis focused on associations between elevated versus low peripheral HIF-1α levels and specific metabolic parameters, including fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), fasting insulin (FINS), and homeostatic model assessment of insulin resistance (HOMA-IR). No specific adverse events or discontinuations were reported in the safety data.

Results indicated a positive association between elevated peripheral HIF-1α and higher fasting plasma glucose, with a mean difference (MD) of 1.13 (95% CI [0.59, 1.67]). Similarly, increased HbA1c was associated with elevated HIF-1α, showing an MD of 0.93 (95% CI [0.63, 1.24]). Elevated HIF-1α levels also correlated with higher fasting insulin (MD = 1.13, 95% CI [0.24, 2.02]) and increased HOMA-IR (MD = 1.40, 95% CI [0.62, 2.18]).

Sensitivity analyses confirmed the robustness of these findings. However, geographic location significantly modified the association with fasting plasma glucose (p = 0.0105). The discordance between elevated systemic levels and known tissue-specific reductions suggests that peripheral HIF-1α may reflect a compensatory response to hypoxia rather than a primary driver of type 2 diabetes pathogenesis. Consequently, these biomarkers should not be interpreted as definitive causal indicators without further validation.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
ImportanceElucidating the role of hypoxia-inducible factor-1α (HIF-1α) in pancreatic β-cell dysfunction is essential for understanding the pathophysiology of type 2 diabetes mellitus (T2DM) and improving clinical risk assessment.ObjectiveTo evaluate associations between protein expression level of HIF-1α in peripheral blood and key glycemic parameters—fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), fasting insulin (FINS), and the homeostatic model assessment of insulin resistance (HOMA-IR)—in patients with T2DM.Data sourcesPubMed, Embase, Cochrane Library, Web of Science (WOS), Wanfang, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), and Chinese Biomedical Literature Service System (SinoMed) were searched from inception to July 28, 2025, for Chinese and English publications.Study selectionObservational studies examining the relationship between HIF-1α levels and glycemic outcomes in T2DM populations.Data extraction and synthesisTwo reviewers independently extracted data and assessed study quality using AHRQ criteria. Random-effects meta-analysis was used to calculate mean differences (MD) with 95% confidence intervals (CI).Main outcomes and measuresDifferences in FPG, HbA1c, FINS, and HOMA-IR between high and low HIF-1α groups with T2DM.ResultsThirty-six studies (n = 5,979) were included. Elevated peripheral HIF-1α was significantly associated with increased FPG (MD = 1.13, 95% CI [0.59, 1.67]), HbA1c (MD = 0.93, 95% CI [0.63, 1.24]), FINS (MD = 1.13, 95% CI [0.24, 2.02]), and HOMA-IR (MD = 1.40, 95% CI [0.62, 2.18]). Subgroup analysis indicated that geographic location significantly modified the FPG association (p = 0.0105). Sensitivity analyses confirmed the robustness of these findings.ConclusionElevated peripheral HIF-1α levels correlate with impaired β-cell function and increased insulin resistance. The discordance between elevated systemic levels and known tissue-specific reductions suggests that peripheral HIF-1α may reflect a compensatory response to hypoxia rather than a primary driver of T2DM pathogenesis.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420251118501, CRD420251118501.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.